Site Search | NIAMS

Displaying 621 - 640 of 1017 results

NIAMS at AAD 2019

https://www.niams.nih.gov/aad-2019

NIAMS at the American Academy of Dermatology 2019 Annual Meeting March 1 – 5, 2019 The following is a selection of presentations by NIAMS and NIAMS-supported researchers. Times are Eastern Standard Time. Friday, March 1 NIAMS Intramural Presentations F014 - Multidisciplinary Management of Chronic GVHD Friday, March 1, 9 –

Hidradenitis Suppurativa (HS)

https://www.niams.nih.gov/health-topics/hidradenitis-suppurativa-hs

Hidradenitis suppurativa (also known as acne inversa) is a chronic, noncontagious, inflammatory condition characterized by pimple-like bumps or boils and tunnels or tracts on and under the skin.

Hidradenitis supurativa

https://www.niams.nih.gov/health-topics/hidradenitis-suppurativa-hs

Aprenda sobre la hidradenitis supurativa, incluyendo cómo se diagnostica y se trata, y las medidas que puede tomar para vivir mejor con esta enfermedad.

Genomic Technology Section

https://www.niams.nih.gov/labs/science-technology/genomic-technology-section

The Genomic Technology Section helps NIAMS investigators solve highly diverse biological and biomedical research questions by providing a diverse portfolio of sequencing services as well as consultation and training for researchers with specific needs or challenging problems. It is a state-of-the-art laboratory facility equipped with the latest DNA sequencing and library preparation technologies.

FY 2020 Congressional Justification

https://www.niams.nih.gov/about/budget/fy2020/congressional-justification

March 2019 FY 2020 Congressional Justification PDF version (1 MB) DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Top NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and

Clinical Research Operations and Management Branch

https://www.niams.nih.gov/about/organization/extramural-program/clinical-research-operations-and-management-branch

The Clinical Research Operations and Management Branch (CROMB) has responsibility for assessing study risk, implementing data and safety monitoring oversight, tracking enrollment progress, and mitigating study related issues for the complete portfolio of NIAMS funded clinical trials and select human subjects observational studies with some level of risk (60-70 studies currently active in the managed portfolio). Specifically, this responsibility includes:

Administrative Management Branch - AMB-EP

https://www.niams.nih.gov/about/organization/extramural-program/administrative-management-branch-amb-ep

The Administrative Management Branch (AMB) is located within the Office of the Director (OD) and is responsible for providing administrative and business management services to the NIAMS Office of the Director and the extramural programs. Administrative staff provide overall administrative support services in the areas of travel, procurement, personnel, budget, timekeeping, property, space, I.D. badges, parking, and general administration to its assigned areas efficiently and effectively to contribute to the mission of the NIAMS.

Financial Management Branch - FMB

https://www.niams.nih.gov/about/organization/office-director/financial-management-branch-fmb

This page is a staff listing page of the people in the Financial Management Branch - FMB

Dr. Sandra Williams is broadly interested in understanding how RNA surveillance pathways link to inflammatory responses and how this could contribute to rheumatic diseases like systemic lupus erythematosus (SLE).

Scleroderma, Fibrosis, and Autoinflammatory Disease Program

https://www.niams.nih.gov/grants-funding/supported-scientific-areas/scleroderma-fibrosis-and-autoinflammatory-disease-program

The Scleroderma, Fibrosis and Autoinflammatory Disease Program supports studies of basic, translational, and pre-clinical studies on scleroderma, fibrosis, and autoinflammatory diseases.

Scleroderma Genomics and Health Disparities Unit Tables

https://www.niams.nih.gov/labs/scleroderma-genomics-and-health-disparities-lap/tables

« Scleroderma Genomics and Health Disparities Unit Table 1. Clinical Manifestations of scleroderma patients in the GRASP cohort (Morgan, Gourh, et al, Medicine 2017) Diffuse Scleroderma Telangiectasia Calcinosis Pulmonary ∥† Fibrosis FVC% pred † ≤70 Pulmonary ¶† Hypertension Scleroderma Renal Crisis Age at onset 0.99 (0.97-1.00) 0.99 (0.98-1.01) 1.00 (0.98-1.01)

SBIR/STTR FAQs

https://www.niams.nih.gov/grants-funding/sbirsttr-faqs

Funding Mechanisms Main Page

Tasha A. Morrison, Ph.D.

https://www.niams.nih.gov/about/directory/tasha-morrison-phd

Dr. Morrison’s research aims to uncover novel molecular mechanisms that regulate the development and function of immune cells. She studies how newly recognized genes regulate the differentiation, activation, and response of natural killer (NK) cells.

Heiyoung Park, Ph.D.

https://www.niams.nih.gov/about/directory/heiyoung-park-phd

Mechanism Table Fiscal Year 2016

https://www.niams.nih.gov/about/budget/fy2016/mechanism-table

September 6, 2017 Fiscal Year 2016 Actual Obligations* Budget Mechanism No. of Awards Amount Research Grants Research Project Grants (RPG): Noncompeting 688 $247,063,147 Administrative Supplements (43) 3,114,022 Competing 251 88,771,455 Subtotal 939 338,948,624 Small Business Innovation/Technology 34 15,578,780 Subtotal, RPGs 973 354,527,404 Research Centers 41 45,603,642 Other Research: Career Programs

FY 2016 Budget Detail For NIAMS

https://www.niams.nih.gov/about/budget/fy2016

September 9, 2017 The Institute often receives questions about the budget. While many of these questions are focused on success rates and paylines, there is also much interest in the Institute’s other funding categories. Since final data for Fiscal Year 2016 are now available, it seemed an opportune time to

Van Nguyen, Ph.D.

https://www.niams.nih.gov/about/directory/van-nguyen-phd

Van Nguyen, Ph.D., SPPIB

NIH Websites Are Changing